Michigan Rep. Tom Barrett’s Complex Relationship with Health Care Industry Funds
Amid scrutiny over campaign financing, Michigan Representative Tom Barrett’s latest campaign ad emphasizes his decision not to accept contributions from private health insurers. Despite these assertions, Federal Election Commission records reveal a more nuanced reality.
In a new campaign advertisement, Barrett claims he returned money to health insurers and urged them to reduce premiums. While he has indeed refunded certain donations, some contributions, notably a $1,000 donation from UnitedHealth Group PAC received in June, remain unreturned.
Despite distancing himself from insurance companies, Barrett continues to receive substantial support from the pharmaceutical sector. His campaigns in 2022 and 2024 have benefited from more than $20,000 contributed by the pharmaceutical industry.
Barrett’s legislative actions have often aligned with pharmaceutical interests. He backed the 2025 One Big Beautiful Bill Act (OBBB), which diminishes Medicare’s negotiating power for drug prices, potentially resulting in an additional $8.8 billion in revenue for pharmaceutical companies, as projected by the Congressional Budget Office.
The OBBB is also set to reduce Medicaid funding by $1 trillion over the next decade, risking health insurance coverage for up to 14,621 of Barrett’s constituents. Additionally, Barrett opposed the extension of Affordable Care Act subsidies, which previously helped lower insurance premiums for approximately 22 million Americans. This decision could lead to about 8,600 individuals in his district losing health coverage.
Barrett’s 2026 campaign gains further momentum from the American Action Network, a conservative group with financial backing from pharmaceutical and insurance sectors. The group has financed television advertisements supporting Barrett.
The Democratic Congressional Campaign Committee has identified Barrett as a vulnerable Republican candidate in the upcoming election, with activist Will Lawrence running against him.
